NYSE · Financials

Oscar Health, Inc. (OSCR)

As-reported financials and recent SEC filings for Oscar Health, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$11.70B

Net income

$-443.2M

Net margin

-3.8%

Diluted EPS

$-1.69

ROE

-45.2%

P/E (TTM)

—

Market cap

$8.98B

Debt / equity

0.4×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$11.70B	$9.18B	$5.86B	$3.96B	$1.84B
Gross profit	—	—	—	—	—
Operating income	$-396.4M	$57.3M	$-235.6M	$-589.9M	$-544.5M
Net income	$-443.2M	$25.4M	$-270.7M	$-606.3M	$-572.6M
Diluted EPS	$-1.69	$0.10	$-1.22	$-2.85	$-3.20

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-06-25

1442026-06-25

1442026-06-23

1442026-06-23

1442026-06-23

1442026-06-23

8-K2026-06-09

42026-06-08

Go deeper on OSCR

Search Oscar Health, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.